[eDisclosure Notice] KOSDAQ - 7 Days

◆J-Way = Decided on a third-party allotment paid-in capital increase to raise 2 billion KRW for operating funds and 5 billion KRW for acquiring securities of other corporations.

◆Neofect = Registered with the U.S. Food and Drug Administration (FDA) for the rehabilitation training device 'Smart Balance.'

◆RSUPPORT = Decided to dispose of treasury stock worth 30.03 million KRW.

◆Hansol C&P = Decided on a bonus issue allocating 4 shares for every 1 common share.

◆BioVille = Applied for commencement of rehabilitation proceedings at the Seoul Bankruptcy Court on the 1st. The reason for the application was explained as 'seeking business normalization through the commencement of rehabilitation proceedings.'

◆T-Robotics = Decided to increase short-term borrowings by 5 billion KRW.